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model of intracerebral hemorrhage
Guofeng Wu1*†, Shujie Sun2†, Fei Sheng1, Likun Wang1 and Fan Wang1Abstract
Objective: To observe the relationship between the perihematomal glutamate levels and the blood–brain barrier
(BBB) permeability in a rabbit model of intracerebral hemorrhage (ICH).
Methods: Seventy-two rabbits were randomly divided into an intracerebral hemorrhage (ICH) model group and a
normal control (NC) group, and each group of 36 rabbits was subsequently divided into 6, 12, 18, 24, 48 and 72 h
groups (n = 6 each). An ICH model was induced by stereotactic injection of autologous, arterial, non-anticoagulated
blood into rabbit basal ganglia. The same procedures were performed in the NC group, but blood was not injected.
The rabbits were sacrificed at specific time points after the experiment began depending on their group.
Perihematomal brain tissues were collected to determine glutamate levels, BBB permeability and brain water
content (BWC).
Results: All of the assessed parameters were increased 6 hour after blood infusion and continued to gradually
increase, peaking at 48 hours. Differences were observed when ICH values were compared with those of the NC
group (p < 0.05).
Conclusions: Perihematomal glutamate increased significantly after ICH. High levels of glutamate are closely
associated with BBB disruption and the brain edema. Therefore, glutamate may play an important role in the
pathogenesis of secondary brain injury after (ICH).
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Evans blueIntroduction
Spontaneous intracerebral hemorrhage (ICH) is a devas-
tating neurological disorder with considerable mortality
and morbidity that accounts for 20%-30% of acute cere-
bral vascular disease. However, no currently available
intervention has been shown to alter the outcome of pa-
tients who have suffered acute ICH (Parker et al. 2010).
Secondary brain damage, which often occurs in the days
following the initial hemorrhage, is closely associated
with significant neurological deterioration (Miller et al.
2007). ICH negatively affects BBB permeability, which* Correspondence: wuguofeng3013@sina.com
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mark of ICH-induced brain injury, BBB disruption is ac-
companied by brain edema in the surrounding areas of
ICH. The degree of BBB breakdown has been directly
correlated with late functional outcome (Lampl et al.
2005). A range of factors including inflammatory media-
tors, thrombin and hemoglobin breakdown products are
involved in BBB disruption (Keep et al. 2008).
Recently, some studies have observed a relationship
between the perihematomal glutamate levels and the
secondary brain injury in ICH models, and the impact of
glutamate on ICH patient outcome (Miller et al. 2007;
Chiang et al. 2006; Hartings et al. 2008; Qureshi et al.
2003; Wang et al. 2008a). Glutamate accumulates during
the early period of experimental hematoma, and the ac-
tivation of N-methyl-D-aspartate (NMDA) receptors bypen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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subsequent neuronal death (Qureshi et al. 2003; Lee
et al. 2006). In cases of ICH, increased levels of glutam-
ate and aspartate that correlate with neurological status
have been detected after subarachnoid hemorrhage
(SAH) (Germano et al. 2007), and glutamate-mediated
excitotoxicity is a major consequence of stroke (Hazell
2007). Blockade of NMDA or AMPA receptors could at-
tenuate BBB disruption in focal cerebral ischemia, and
treatment with magnesium, MK-801 and a combination
of magnesium and MK-801 can reduce brain edema for-
mation and can help restore BBB integrity after experi-
mental diffuse brain injury (Imer et al. 2009). Reducing
perihematomal glutamate level by minimally invasive
procedures for intracerebral hematoma also decreases
BBB permeability and BWC (Wu et al. 2011). These re-
sults demonstrate that secondary brain damage is associ-
ated with glutamate-related excitotoxicity, and glutamate
levels are closely associated with ICH patient outcome.
However, the exact relationships among elevated glu-
tamate levels in perihematomal brain tissues, BBB per-
meability and brain edema have not been thoroughly
investigated.
The objective of the current study was to determine
the relationship between the perifocal glutamate levels




Formamide (molecular formula: HCONH2, Chongqing
Chuanjiang Chemical Reagent Factory, Chongqing,
China), urethane (molecular formula: C3H7NO2, Wuxi
Yangshan Biochemical), Evans blue (Beijing Hengye
Zhongyuan Chemical), 4% paraformaldehyde (Wuhan
Boster Biological Technology), urokinase (Guangdong
Livzon Pharmaceutical), glutamate (Sigma), derivatization
reagent borate buffer (Agilent Technologies, USA), FMOC
reagent Agilent PN5061-3337 (Agilent Technologies,
USA), OPA reagent Agilent PN5061-3335 (Agilent
Technologies, USA, 2,4-DNFB (Japan) and HPLC-grade
acetonitrile and methanol (Germany) were used in this
study.
Main instruments
We used the following instruments: a ZH-Lanxing B-
Type rabbit stereotaxic Apparatus (Huaibei Zhenghua
Biological Instrument & Equipment), electronic scales
(Satourious, Germany), a Rainbow Type-722 grating
spectrophotometer (Shandong Gaomi Rainbow Analyt-
ical Instrument), a 5415R high-speed centrifuge (Frozen,
Heraeus Company), micropipettes (Eppendorf ), a 202–2
constant temperature oven (Shanghai Luda Laboratory
Apparatus), a digital display thermostat water bath (HH-2;Guohua Electric Appliance), a tabletop general centri-
fuge (TGL-16B; Shanghai Anting Scientific Instrument
Factory), a −80°C freezer (Forman Scientific Company), a
refrigerator (Qingdao), a CT provided by the Guiyang
Medical College, a high-performance liquid chromato-
graph (HP-1100; Agilent Technologies, USA), a G1315 A
diode-array detector (DAD, Agilent Technologies, USA),
a pH meter (410 A, ORION, USA), an Agilent 1313A
Automatic Sampler (Agilent Technologies, USA), a
column oven (Agilent Technologies, USA) and scales
(Beijing Gangdong Hengye Instrument).
Experimental groups
The present study was approved by the Animal Care
and Use Committee of Guiyang Medical College.
Seventy-two male rabbits (2.8-3.4 kg) were provided
by the Animal Center of Guiyang Medical College. The
animals were divided randomly into an ICH group and a
NC group (n = 36 each), and they were equally divided
into 6 subgroups (n = 6 each) that were sacrificed at 6,
12, 18, 24, 48 or 72 h after ICH induction. ICH was in-
duced in all animals in the model group.
Animal preparation
ICH model preparation
Rabbits were fasted for 12 hours and water restricted for
4 hours prior to the experiment. The rabbits were then
anesthetized by injecting 20% urethane (5 ml/kg) into
the ear vein. Slow breathing, a slow corneal reflex and
no pain reaction were used as indicators of complete
anesthetization. The head of the rabbit was then shaved
to expose the skin for surgery.
The anesthetized rabbit was fastened to the stereotaxic
apparatus, and the skin in the operation field was
disinfected with 75% alcohol. A 3-cm incision was made
along the mid-line between the two post-orbital margins,
and the subcutaneous fascia was stripped to expose the
skull. A 3% H2O2 solution was used to open the perios-
teum and expose the bregma and lambdoid sutures. The
head was then adjusted to make the bregma 1.5 mm
higher than the lambdoid suture. The position of the
internal capsule was located according to the rabbit
stereotaxic atlas. The coronal plane crossing the center
of bregma was used as the coronal zero plane (AP0); A1
represented the coronal plane 1 mm rostral to the AP0,
and the internal capsule was estimated to be between A5
and P2. The present experiment used the A1 level and
the bregma as base points, with the puncture point
6 mm left of the coronal suture and 1 mm parallel to
the sagittal suture. A hole was drilled in the skull, and a
#12 needle and a 1-ml syringe were used to deliver
0.8 ml autologous arterial blood taken from the central
ear artery. The syringe was then connected to a #7 nee-
dle in without a tip. Air was completely removed from
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quickly inserted vertically 12 mm into the skull, and the
blood was slowly injected into the basal ganglia. The in-
jection lasted for approximately 3 minutes. The needle
was left in place for 8 min after the injection to prevent
blood backflow, and then the needle was slowly re-
moved. Local hemostasis was induced by compression
for 2 min.
The drill hole was then covered using gutta-percha. A
CT scan was performed 3 hours later. A hyperdensity
shadow in the basal ganglia region without a shadow
in the lateral ventricle was considered as a successful
model of ICH.
After successful ICH induction confirmed by CT scan,
the animals were returned to the housing facility. All the
animals recovered from anesthesia within 5 hours after
intravenous injection of 20% urethane. Exclusion criteria
included visualization of back flow along the needle
track, blood in the ventricle, and death.
NC group treatment
Procedures performed in the ICH group were identical
in the NC group, but autologous arterial blood was not
injected into the basal ganglia to induce intracerebral
hematoma.
Medical treatment of the animals
Animals received an intramuscular injection of penicillin
(400,000 U) to prevent infection. They were housed as
usual until they were sacrificed. No other medical treat-
ment was administered.
Intracerebral hematoma volume and neurological deficit
score
To demonstrate that ICH was successfully modeled,
hematoma volume was measured with a CT scan, and a
neurological deficit scale was used to assess neurological
functions (Purdy et al. 1989). The scale included tests of
motor function (Parker et al. 2010; Miller et al. 2007; Shi
et al. 2011; Lampl et al. 2005), consciousness (Parker et al.
2010; Miller et al. 2007; Shi et al. 2011; Lampl et al. 2005),
head turning (0–1), circling (0–1) and hemianopsia (0–1).
A total score of 11 indicates maximum impairment
(comatose or dead rabbit), whereas 2 denotes complete
normality. Tests were conducted by an observer blinded
to the animals. The tests were conducted by an observer
blinded to the animal’s group.
Brain tissues preparation
A 2% Evans blue (2 ml/kg) solution was injected into the
ear vein 2 hours before euthanization. The animals were
then anesthetized using 20% urethane, and the chest was
quickly opened to expose the heart. A tube was inserted
from the left ventricle into the aortic root, with a smallhole cut in the right ventricle to allow the tube to exit.
Rabbits were transcardially perfused with 400 ml 0.9%
sodium chloride solution until the fluid flowed clear, at
which time they were perfused with 100 ml 4% parafor-
maldehyde. The brain was then extracted and placed on
ice. The needle track was used as the center to prepare
coronal and sagittal sections, then the brain on the
hematoma side was cut and divided into four parts:
front-inner, front-outside, back-inner and back-outside.
A total of 5 mm of brain tissue surrounding the
hematoma was collected from each area. The front-inner
and front-outside parts were used for amino acid testing,
the back-inner part was used for assessing Evans blue
content, and the back-outside part was used for testing
BWC.
Perihematomal glutamate level measurement
Perihematomal glutamate content was determined using
high-performance liquid chromatography.
Chromatographic conditions
A ZORBAX Eclipse-AAA (4.6 × 150 mm, 5 μm) chroma-
tographic column was used. Mobile phase A was 40 mM
Na2HPO4, pH 7.8 (5.5 g Na2HPO4 · H2O + 1 l water,
NaOH was added to make the pH 7.8) and mobile phase
B was 45:45:10 (V/V/V) ACN: MeOH:water. The col-
umn was run with a flow rate of 2 ml/min. Phase B in-
creased from 0 to 57% between 0 and 18 min and from
57 to 100% between 18.1 and 18.6 min. It remained at
100% between 18.6 and 22.3 min and decreased from
100% to 0% between 22.3 min and 23.2 min. Between
23.2 and 26 min, Phase B remained at 0%. The column
temperature was 40°C, and the sampling volume was
10 μl. The diode array wavelength was 262 nm, and the
reference wavelength was 324 nm.
Derivative solution preparation
A total of 25 mg OPA was dissolved in 1 ml methanol.
Sodium borohydride buffer (4 mol/l) was then added
(pH 10.4), and the solution was stirred. The final solu-
tion was stored at 4°C.
Standard solution preparation
Glutamate and 0.2 mol/l NaHCO3 (pH 9.8) was used to
make a 1-g/l standard stock solution.
Biosample preparation
The brain tissue was defrosted, weighed and placed in a
dry glass homogenizer. Dilute hydrochloric acid (1:5 w/v,
0.1 mmol/l) was added, and the homogenized brains
were placed into an ultrasonicator (Temp: 4°C; pulse for
2 s, rest for 2 s; intensity: 20%; 15 times in total). Sam-
ples were then centrifuged at 1,200 rpm for 20 min
at 4°C. Borate saline buffer (2.5 μl) was then added to
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by the addition of 0.5 μl OPA. The sample was then mixed
for 30 s before FMOC (0.5 μl) was added and the solution
was mixed for another 30 s. Finally, water (32 μl) was
added, and the final sample was mixed for 30 s, and 10 μl
of the sample was used.
Calculation of glutamate concentration
The peak area of glutamate from the HPLC was inte-
grated and used as an external standard for the samples.
The glutamate concentration for 1 g of brain tissue was
then calculated according to the sample quality.
Determination of BBB permeability
Experimental methods
Evans blue was used as a tracer to measure BBB perme-
ability. Two hours before each experiment, 2% Evans
blue (2 ml/kg) was injected into the ear vein. After 2 h,
the brain tissue was quickly removed. The tissue sur-
rounding the hematoma was weighed (within 0.1 mg)
and then placed into a test tube with 4 ml formamide.
The tube was then capped and placed in a 54°C water
bath for 24 h to allow the Evans blue to spread through-
out the brain tissue.
The samples were then centrifuged at 2,400 rpm for
5 min. The supernatant was placed in a quartz cuvette,
and a spectrophotometer was used (λ = 632 nm) to
measure the absorbance of the supernatant. Formamide
was used as a blank control.
Setting up the standard curve
Evans blue (4 mg) was placed into a volumetric flask and
weighed (within 0.1 mg). A total of 100 ml NS was
added, and the solution was stirred. From this solution,
0.3 ml was removed and placed in 5.7 ml of formamide
to make the standard buffer solution. A total of 3 ml of
this solution was serially diluted in seven tubes each
containing 3 ml formamide. The amount of Evans blue
in each of the seven tubes was 8, 4, 2, 1, 0.5, 0.25 and
0.125 μg/ml. The tubes were capped and placed into
a 54°C water bath for 24 hours. The aforementioned
method was used to measure absorbance. Linear regres-
sions were calculated for the absorbencies and Evans blue
content. The final equation was y = 0.0053 × + 0.0608
(R2 = 0.9833).
Evans blue content computation
We used the formamide method to measure Evans blue
content in brain tissue to assess BBB damage severity.
The formula used was as follows: Evans blue content in
brain tissue (μg/g wet brain) = B × formamide (ml)/wet
weight (g), where B refers to the Evans blue content of
the sample (μg/ml) given by the linear regression equa-
tion according to standard curve.Measurement of BWC
The dry and wet weight method was used to measure
BWC. The brains were quickly removed, and brain tis-
sue from the back-outside portion of the hematomas
was used. First, the weight of the wet tissue was
obtained. The samples were then placed in an oven at
100°C for 48 h, and the dried samples were then
weighed. BWC was then calculated as (wet weight–dry
weight)/wet weight × 100%.
Statistical analysis
All data were analyzed using SPSS 11.5. Basic data are
expressed as the mean ± standard deviation (X ± SD). A
Kruskal-Wallis test was used to make comparisons
across the whole time series among the groups. If the
Kruskal-Wallis test detected significant differences,
Bonferroni corrections were used to make compari-
sons between groups. A correlative analysis was also
performed to assess the relationship between the glu-
tamate level and the BBB permeability. A p value
less than 0.05 was considered statistically significant.
Statistical analysis was performed with the help of
the Department of Biostatistics of Guiyang Medical
College.
Results
Following blood infusion into the basal ganglia, the ani-
mals were unable to stand up or crawl. The contralateral
extremities were less responsive to noxious stimulation.
Brain CT showed an oval or round hyperdensity in the
basal ganglia (Figure 1). The abovementioned observa-
tions demonstrate that the ICH model in this study was
successful and reliable.
Three rabbits were excluded from this study, one ani-
mal died of overdose of anesthetic agents during surgery,
and the other two did not show evidence of hematoma
formation. A total of 33 rabbits in the ICH group (5 in
the 6 h group, 6 in the 12 h group, 6 in the 18 h group,
5 in the 24 h group, 5 in the 48 h group and 6 in 72 h
group) and 36 rabbits in the NC group were included in
the present study.
Hematoma volume and neurological function
The hematoma volume and neurological deficit score in
each subgroup were determined after the model was
successfully induced. The average hematoma volume
ranged from 0.250 ± 0.014 ml to 0.266 ± 0.012 ml, and
no significant difference was observed among sub-
groups. The neurological deficit score (8.833 ± 0.753
to 9.167 ± 0.817) increased immediately after the blood
was infused in the ICH group compared with the NC
group, and no remarkable difference was noted among
subgroups. These results suggested that the ICH model
was successful.
Figure 1 Brain CT and histological section showing hematoma in the rabbit`s brain. The arrow pointed to the basal ganglia hematoma on
histological section (A) or brain CT (B).
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The glutamate level began to increase 6 hours after
blood infusion. It gradually increased over time and
peaked at 48 hours, which was significantly different
compared with the NC group (p < 0.05). The glutamate
level changed over time after blood was infused into the
brain (χ2 = 20.134). When comparisons were performed
between subgroups, the glutamate level was lowest in 6-
hour group, also the Evans blue (χ2 = 20.134) and the
BWC (χ2 = 20.142). These values were highest in 48-h
group (Wilcoxon W= 27 when the 6-h group was com-
pared with the 48-h group, Wilcoxon W= 21 when the
6-h group was compared with the other groups),
suggesting that less brain damage had occurred in the
early stage after ICH, indicating that it might be an opti-
mal time window for intervention (Table 1).
In the NC group, no significant differences were
observed between subgroups at different time points
(p > 0.05), suggesting that the simple puncture of brain
tissue with a needle has little impact on glutamate levels
in brain tissue around the needle tract (Table 1).
BBB permeability and BWC
Evans blue and BWC around the hematoma began to in-
crease 6 hours after successful ICH induction, increasedTable 1 Changes of perifocal glutamate level, Evan`s blue and
Time point Glutamate content(μg/g) Evan
ICH group NC group ICH g
6 hour 2286.34 ± 43.78◇# 2219.11 ± 33.67 28.86
12 hour 2317.64 ± 65.18 2184.51 ± 47.12 29.19
18 hour 2361.54 ± 51.84 2231.32 ± 39.54 32.19
24 hour 2438.62 ± 42.56 2213.98 ± 50.38 33.76
48 hour 2479.13 ± 59.67 2198.36 ± 42.87 35.36
72 hour 2480.23 ± 49.60 2210.88 ± 45.66 34.96
◇Compared with the NC group (P < 0.05). #Compared with other subgroups (P < 0.0gradually over time after blood infusion and peaked at
48 hours (Wilcoxon W= 27 when the 6 h group was
compared with 48 h group, Wilcoxon W = 21 as 6 h
group was compared with the other groups) ,suggesting
that BBB disruption began in the early stage. Compared
with the NC group, significant differences were observed
for Evans blue content at different time points (at 6 h,
12 h, 18 h, 24 h, 48 h and 72 h) ,also the brain water
content The same phenomenon was observed in
perihematomal brain water content.
These results suggest that BBB permeability and brain
edema both increased (Table 1). The range of the brain
edema was observed on histological sections. Tissue ap-
proximately 5 mm around the hematoma became
edematous, but the results were not quantified.
No significant difference was observed in Evans blue
content or BWC among subgroups at different time
points (p > 0.05) in the NC group, suggesting that a sim-
ple puncture of brain tissues does not decrease BBB per-
meability around the needle tract.
Correlation between glutamate level and BBB disruption
A correlation analysis was performed to analyze the rela-
tionship between perifocal glutamate levels and BBB per-
meability. Positive correlations was observed betweenBEC in a rabbit model of ICH
`s blue content(μg/g) Brain water content(%)
roup NC group ICH group NC group
± 0.87◇# 4.14 ± 0.21 78.14 ± 0.74◇# 77.17 ± 0.44
± 1.06 3.96 ± 0.13 79.86 ± 0.54 77.06 ± 0.43
± 0.74 4.21 ± 0.25 81.19 ± 0.41 76.98 ± 0.81
± 1.18 4.17 ± 0.18 81.65 ± 0.82 77.45 ± 0.91
± 1.18 4.08 ± 0.27 81.92 ± 0.68 77.38 ± 0.67
± 1.20 4.20 ± 0.22 81.96 ± 0.53 77.43 ± 0.78
5).
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p < 0.05) and between glutamate level and BWC (r = 0.841,
p < 0.05). The same correlation was also observed between
BBB permeability and BWC (r = 0.841, p < 0.05). We found
that the higher glutamate levels were associated with more
serious BBB disruption and cerebral edema, suggesting
that the perihematomal glutamate level was highly as-
sociated with BBB disruption and brain edema forma-
tion (Figure 2). Further observation demonstrated that
the glutamate vs. Evans blue and glutamate vs. BWC
plots display a sigmoidal relationship.
Discussion
Intracerebral hemorrhage remains the least treatable
form of stroke (Rincon & Mayer 2008). ICH models
serve as an important tool for understanding mecha-
nisms underlying brain injury after an intracerebral
bleed (Andaluz et al. 2002). Based on previously pub-
lished studies of an ICH model (Andaluz et al. 2002;
Frantzias et al. 2011), we successfully generated a rabbit
model of ICH by stereotactic injection of 0.3 ml non-
anticoagulant autologous arterial blood into the basal
ganglia. The volume of the rabbit`s brain is approxi-
mately 1 percent of the human brain (Narushima et al.Figure 2 Correlation between the glutamate level and BBB disruption
has a positive correlation with the Evans blue content (A) and the BWC (B
content and the BWC (C).2003), so this injection is approximately equivalent to
about 30 ml of hematoma in the human brain. In the
present study, an ICH model was induced successfully
in 33 rabbits out of 36 ones. Three rabbits were excluded
from the study as there is no evidence of hematoma for-
mation. For experimental purposes, the most common
technique of producing an intracerebral hematoma in rab-
bits is the injection of unclotted autologous blood. Some-
times,the injected blood may ruptures into the ventricular
system or it extends to the subarachnoid or subdural
space (Deinsberger et al. 1996). Therefore, a CT scan was
performed after successful ICH injection 3 hours later. If
postoperative brain CT does not show an oval or round
hyperdensity in the basal ganglia,we do not consider that
there is a hematoma formation.
ICH is always followed by blood–brain barrier disrup-
tion, which contributes to the enhanced BBB permeabil-
ity and vasogenic brain edema in the surrounding areas.
Brain edema is one of the most frequent and serious
complications of ICH, but how the ICH causes brain
edema remains unknown (Wu et al. 2008). Previously
published reports demonstrated that a range of factors
are involved in BBB disruption (Keep et al. 2008). Stud-
ies in recent years have observed a relationship betweenand brain edema formation. The perihematomal glutamate content
). The same correlation was also observed between the the Evans blue
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ary brain injury in models of ICH and the impact of glu-
tamate on ICH patient outcome (Miller et al. 2007;
Chiang et al. 2006; Hartings et al. 2008; Qureshi et al.
2003; Wang et al. 2008a). Glutamate is accumulated
during the acute period of experimental hematoma,
and the activation of NMDA receptors by glutamate can
result in calcium influx and neuronal death following ICH
(Lee et al. 2006). Secondary brain damages are associated
with glutamate-related excitotoxicity, and the level of glu-
tamate is closely associated with ICH patient outcome.
Patients with spontaneous ICH who presented with more
serious brain injuries had a higher concentration of glu-
tamate in the brain and poorer prognosis (Wang et al.
2008b).
In the present study, perifocal glutamate levels began
to increase 6 hours after infusing blood into the basal
ganglia. As the time after infusing the blood into the
brain was prolonged, the glutamate level increased grad-
ually and peaked 48 hours after successful ICH induc-
tion. The perifocal glutamate level varied in subgroups
at different time points. It was lowest in the 6-h group
and highest in the 48 and 72 h group. We observed
statistically significant increases of perihematomal glu-
tamate at different time points compared with the
NC group, suggesting that glutamate level increase is
a pathological process that follows ICH.
Evans blue is a type of dark blue powdered dye that is
unable to penetrate the BBB in normal conditions. The
Evans blue assay is a popular method for quantifying
BBB disruption. A small amount of Evans blue was ob-
served in normal animal brains after intravenous injection
(Wu et al. 2011). In the present studies, perihematomal
Evans blue content was significantly increased in the ICH
groups at different time points compared with the control
group, demonstrating that the BBB was disrupted after the
intracerebral infusion of blood. BBB disruption was
followed by brain edema formation. Perihematomal BWC
began to increase in the 6-h group and peaked 48 hours
after ICH was induced. The change of BWC was consist-
ent with enhanced BBB permeability. The range of edema-
tous brain area was observed on histological sections. An
area extending at least 5 mm from the hematoma became
edematous, but because we only collected a total of 5 mm
of brain tissue around the area to measure BWC, we were
unable to precisely quantify the range of brain edema.
This is a limitation of the present study.
The increased perifocal glutamate positively correlated
with enhanced BBB permeability and increased BWC.
Higher perihematomal glutamate levels were indicative
of more serious BBB disruption and brain edema. Further
observation demonstrated that the glutamate vs. Evans
blue and glutamate vs. BWC plots display a sigmoidal re-
lationship.,suggesting that the BBB permeability or theBWC increased slightly in the early stage as the glutamate
level elevated. They increased dramatically as the glutam-
ate level continue to increase. However, the increase of
the BBB permeability or the WBC become lower after the
glutamate level reaches to a certain extent. The relation-
ship between the Evans blue and the BWC also display
similar results.
However, the mechanism underlying increased perihema-
tomal glutamate remains poorly understood. One possibil-
ity is an influx of glutamate from the initial hematoma into
the extracellular space during ICH (Wagner et al. 1998). It
is also possible that glutamate enters perihematomal brain
tissue from the bloodstream following BBB disruption.
Although the mechanism behind increased glutamate
after ICH remains poorly understood, glutamate has
been demonstrated to be involved in BBB disruption
(Fu et al. 2007). It is reasonable for us to postulate
that perihematomal BBB disruption is due to increased
glutamate content. High levels of the glutamate activate
NMDA receptors, consequently resulting in the entry of
large amount of Ca2+ into the neurons, resulting in neur-
onal necrosis or apoptosis (Nicholls et al. 2007). Elevated
glutamate levels in perihematomal brain tissues resulted
in increase BBB disruption and permeability, thereby
aggravating brain edema. Our results corroborate these
findings. Because perihematomal glutamate level is closely
associated with BBB disruption and brain edema forma-
tion, reducing glutamate levels or antagonizing its effect
in the early stages of ICH might be effective in treating
secondary brain edema. However, the current study
focused on the relationship of glutamate levels and
the BBB permeability, and because the animals were
sacrificed 72 hours after ICH induction, we were un-
able to observe a correlation between glutamate levels
and neurofunctional recovery.
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